PubRank

Thierry Brue

Author PubWeight™ 65.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 2006 2.56
2 Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev 2003 1.93
3 Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab 2002 1.74
4 Ketoconazole in Cushing's disease: is it worth a try? J Clin Endocrinol Metab 2014 1.72
5 High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol 2011 1.69
6 Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 2007 1.53
7 Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. J Clin Endocrinol Metab 2010 1.46
8 Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev 2006 1.35
9 A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J Clin Endocrinol Metab 2009 1.32
10 Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations. J Clin Endocrinol Metab 2004 1.29
11 Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 2010 1.24
12 Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. J Clin Endocrinol Metab 2012 1.24
13 PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption. J Clin Endocrinol Metab 2012 1.19
14 The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodeling. Genes Dev 2012 1.16
15 A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 2013 1.15
16 Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 2009 1.14
17 Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J Clin Endocrinol Metab 2007 1.11
18 Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment. Clin Endocrinol (Oxf) 2012 1.08
19 Epilepsy related to hypothalamic hamartomas: surgical management with special reference to gamma knife surgery. Childs Nerv Syst 2006 1.07
20 Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 2010 1.05
21 Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocr Relat Cancer 2009 1.03
22 Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. J Clin Endocrinol Metab 2006 1.02
23 Pituitary stem cell update and potential implications for treating hypopituitarism. Endocr Rev 2011 0.99
24 Cushing's disease. Orphanet J Rare Dis 2012 0.98
25 Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets. Clin Pharmacokinet 2010 0.95
26 Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis. Eur J Endocrinol 2013 0.94
27 Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency. Pituitary 2011 0.93
28 Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up. J Clin Endocrinol Metab 2010 0.93
29 Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients. Eur J Endocrinol 2012 0.92
30 Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab 2005 0.92
31 Role of stereotactic radiosurgery in the management of pituitary adenomas. Nat Rev Endocrinol 2010 0.92
32 Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis. Mol Endocrinol 2010 0.92
33 An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. J Clin Endocrinol Metab 2005 0.91
34 Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. J Clin Endocrinol Metab 2005 0.89
35 Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. Eur J Endocrinol 2011 0.89
36 Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomas. Cancer Res 2008 0.87
37 Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cells. Hum Gene Ther 2012 0.87
38 Inactivation of PITX2 transcription factor induced apoptosis of gonadotroph tumoral cells. Endocrinology 2011 0.86
39 Gamma knife surgery for epilepsy related to hypothalamic hamartomas. Semin Pediatr Neurol 2007 0.85
40 Pituitary apoplexy after somatostatin analogue administration: coincidental or causative? Clin Endocrinol (Oxf) 2013 0.84
41 Medical treatment of Cushing's syndrome: glucocorticoid receptor antagonists and mifepristone. Neuroendocrinology 2010 0.83
42 Outcome of multimodal therapy in operated acromegalic patients, a study in 115 patients. Clin Endocrinol (Oxf) 2013 0.83
43 Bilateral neck exploration in patients with primary hyperparathyroidism and discordant imaging results: a single-centre study. Eur J Endocrinol 2014 0.82
44 A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies. J Clin Endocrinol Metab 2004 0.82
45 Activin inhibits the human Pit-1 gene promoter through the p38 kinase pathway in a Smad-independent manner. Endocrinology 2006 0.81
46 Radiotherapy and radiosurgery in acromegaly. Pituitary 2009 0.81
47 A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease. J Clin Endocrinol Metab 2009 0.81
48 The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease. Eur J Endocrinol 2004 0.81
49 Deficit in anterior pituitary function and variable immune deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infections. J Clin Endocrinol Metab 2011 0.81
50 Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. J Clin Endocrinol Metab 2003 0.80
51 The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome. Curr Opin Endocrinol Diabetes Obes 2012 0.79
52 Lessons learned from 15 years of KIMS and 5 years of ACROSTUDY. Horm Res Paediatr 2011 0.79
53 Unilateral agenesis of internal carotid artery associated with congenital combined pituitary hormone deficiency and pituitary stalk interruption without HESX1, LHX4 or OTX2 mutation: a case report. Pituitary 2012 0.79
54 Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds. Endocr Relat Cancer 2012 0.79
55 The role of CBP/p300 interactions and Pit-1 dimerization in the pathophysiological mechanism of combined pituitary hormone deficiency. J Clin Endocrinol Metab 2005 0.79
56 Delayed diagnosis of Sheehan's syndrome in a developed country: a retrospective cohort study. Eur J Endocrinol 2013 0.78
57 Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment. Ann Endocrinol (Paris) 2012 0.78
58 Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatment. Int J Cancer 2007 0.78
59 Comparative validation of the growth hormone-releasing hormone and arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone assay conforming to recent international recommendations. J Clin Endocrinol Metab 2010 0.78
60 Truncation of PITX2 differentially affects its activity on physiological targets. J Mol Endocrinol 2010 0.78
61 Clinical, biological and genetic analysis of 8 cases of congenital isolated adrenocorticotrophic hormone (ACTH) deficiency. PLoS One 2011 0.77
62 Genetic causes of combined pituitary hormone deficiencies in humans. Ann Endocrinol (Paris) 2012 0.77
63 [Tpit mutations reveal a new model of pituitary differentiation and account for isolated ACTH deficiency]. Med Sci (Paris) 2004 0.76
64 Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogs. J Clin Endocrinol Metab 2014 0.76
65 R31C GNRH1 mutation and congenital hypogonadotropic hypogonadism. PLoS One 2013 0.76
66 [Radiotherapy and radiosurgery of pituitary adenomas]. Presse Med 2008 0.75
67 Identification and functional analysis of the novel S179R POU1F1 mutation associated with combined pituitary hormone deficiency. J Clin Endocrinol Metab 2006 0.75
68 Case seminar: a young female with acute hyponatremia and a sellar mass. Endocrine 2011 0.75
69 [Congenital hypopituitarism: when should transcription factor gene screenings be performed?]. Presse Med 2004 0.75
70 [Future of endocrinology: new concepts, new approaches, new treatments]. Ann Endocrinol (Paris) 2008 0.75
71 Gamma Knife radiosurgery in pituitary adenomas: Why, who, and how to treat? Discov Med 2010 0.75